Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT00087724

Public ClinicalTrials.gov record NCT00087724. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of FK962 in Subjects With Mild to Moderate Alzheimer's Disease

Study identification

NCT ID
NCT00087724
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
510 participants

Conditions and interventions

Interventions

  • FK962 Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2004
Primary completion
Not listed
Completion
Aug 31, 2006
Last update posted
Jun 6, 2012

2004 – 2006

United States locations

U.S. sites
72
U.S. states
31
U.S. cities
66
Facility City State ZIP Site status
Investigational Site Phoenix Arizona 85013
Investigational Site Phoenix Arizona 85032
Not listed Sun City Arizona 85351
Investigational Site Tucson Arizona 85724
Investigational Site Little Rock Arkansas 72205
Investigational Site Little Rock Arkansas 72211
Investigational Site Fresno California 93720
Investigational Site Irvine California 92618
Investigational Site Orange California 92656
Investigational Site San Francisco California 94115
Investigational Site Sherman Oaks California 91403
Investigational Site Torrance California 90505
Investigative Site Denver Colorado 80249
Investigational Site Denver Colorado 80262
Investigational Site Darien Connecticut 06820
Investigational Site Hamden Connecticut 06518
Not listed Hamden Connecticut 06518
Investigational Site Stamford Connecticut 06902
Investigational Site Fort Myers Florida 33912
Investigational Site Hialeah Florida 33016
Investigational Site Hollywood Florida 33021
Investigational Site Miami Florida 33176
Investigational Site North Miami Florida 33161
Investigational Site Ocala Florida 34471
Investigational Site Port Charlotte Florida 33952
Investigational Site Sarasota Florida 34243
Investigational Site Sebring Florida 33872
Investigational Site Tampa Florida 33613
Not listed West Palm Beach Florida 33407
Investigational Site Snellville Georgia 30078
Not listed Snellville Georgia 30078
Investigational Site Elk Grove Illinois 60007
Investigational Site Wichita Kansas 67207
Investigational Site New Orleans Louisiana 70112
Not listed Baltimore Maryland 21208
Investigational Site Newton Massachusetts 02459
Not listed Livonia Michigan 48152
Not listed Hattiesburg Mississippi 32401
Investigational Site St Louis Missouri 63128
Investigational Site Las Vegas Nevada 89102
Investigational Site Long Branch New Jersey 07740
Investigational Site Paterson New Jersey 08759
Investigational Site Piscataway New Jersey 08855
Investigational Site Albuquerque New Mexico 87102
Investigational Site Albany New York 12208
Investigational Site Buffalo New York 14221
Investigational Site Lawrence New York 11559
Investigational Site New York New York 10021
Investigational Site White Plains New York 10605
Not listed Charlotte North Carolina 28204
Investigational Site Centerville Ohio 45459
Investigational Site Columbus Ohio 43210
Not listed Dayton Ohio 45408
Investigational Site Dayton Ohio 45415
Investigational Site Toledo Ohio 43623
Investigational Site Oklahoma City Oklahoma 73112
Investigational Site Tulsa Oklahoma 74104
Investigational Site Eugene Oregon 97401
Investigational Site Medford Oregon 97504
Investigational Site Bala-Cynwyd Pennsylvania 19004
Investigational Site Jenkintown Pennsylvania 19046
Investigational Site Pawtucket Rhode Island 02860
Investigational Site Johnson City Tennessee 37601
Investigational Site Nashville Tennessee 37203
Investigational Site Houston Texas 77063
Investigational Site San Antonio Texas 78229
Investigational Site Wichita Falls Texas 76309
Investigational Site Salt Lake City Utah 84121
Investigational Site Bennington Vermont 05201
Not listed Burlington Vermont 05401
Investigational Site Norfolk Virginia 23507
Investigational Site Milwaukee Wisconsin 53227

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00087724, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 6, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00087724 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →